Target intelligence / Profile preview

AFG3L2 pseudogene 1 (AFG3L2P1)

Target
AFG3L2P1
Molecular classification
Other (pseudogene)
01

Overview

AFG3L2 pseudogene 1 (AFG3L2P1), also known as AFG3L1 in humans, is a non-functional pseudogene related to the functional AFG3L2 gene. In humans, AFG3L1 has lost its protein-coding potential and does not produce an active protein, nor does it participate in m-AAA protease complex formation. While the functional AFG3L2 gene encodes a mitochondrial AAA+ protease subunit essential for protein quality control and mitochondrial function, the AFG3L2P1 pseudogene itself does not contribute to these activities or any other biological functions in humans. Unlike the mouse ortholog, human AFG3L1 is nonfunctional, even though it may show low-level expression. AFG3L2P1 is not considered an active target, enzyme, or receptor, and there are no known drugs, clinical biomarkers, or therapeutic applications associated with it. Mutations in the functional AFG3L2 gene have been linked to neurodegenerative disorders like spinocerebellar ataxia, but the pseudogene has no such associations.

Other names
AFG3L1AFG3L2P1

Beyond the preview

Go deeper on AFG3L2 pseudogene 1 (AFG3L2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AFG3L2 pseudogene 1 (AFG3L2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call